Reduction of CD8(+) T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate

OBJECTIVE: To evaluate the influence of dimethyl fumarate (DMF, Tecfidera) treatment of multiple sclerosis (MS) on leukocyte and lymphocyte subsets. METHODS: Peripheral blood leukocyte and lymphocyte subsets, including CD3(+), CD4(+), and CD8(+) T cells; CD19(+) B cells; and CD56(+) natural killer (...

Descripción completa

Detalles Bibliográficos
Autores principales: Spencer, Collin M., Crabtree-Hartman, Elizabeth C., Lehmann-Horn, Klaus, Cree, Bruce A.C., Zamvil, Scott S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335821/
https://www.ncbi.nlm.nih.gov/pubmed/25738172
http://dx.doi.org/10.1212/NXI.0000000000000076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335821/
https://www.ncbi.nlm.nih.gov/pubmed/25738172
http://dx.doi.org/10.1212/NXI.0000000000000076

Ejemplares similares